SynthesisThe Cochrane database of systematic reviews2015

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.

James B Geake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.